Hepatitis C Treatment: Meeting Our Patients Wherever They Are

Friday, April 25, 2025

3:00 PM – 4:15 PM

Presenter(s)

Sarah Rowan, MD

Associate Professor
Denver Health and Hospital Authority
Denver, Colorado
Kevin Kamis, MPH

Clinic Administrator
Public Health Institute at Denver Health
Denver, Colorado
RK

Ruth Kanatser

Assistant Director
Harm Reduction Action Center
Denver, Colorado
Hannan M. Braun, MD

Internal Medicine & Addiction Medicine Physician
Denver Health
Denver, Colorado

Hepatitis C (HCV) disproportionately affects people who use drugs, yet treatment rates for people who use drugs remain low. This interactive session will educate participants on the "Simplified Approach" to HCV treatment and describe successful HCV treatment programs in nontraditional settings in Denver, CO. We will focus on our syringe service program-based HCV treatment initiative as well as our approach to HCV treatment provision within our opioid treatment program.

Learning Objectives:

Learners will be able to:

Explain and discuss the simplified approach to hepatitis C testing and treatment as recommended in the U.S. national guidelines.
Describe nontraditional settings for HCV treatment that increase access for people who use drugs. Analyze the challenges of nontraditional approaches and conceptualize solutions to enable implementation of new HCV programs.
Reflect on patient stories and perspectives on their HCV treatment experience.

Disclosure(s):

Sarah Rowan, MD: No financial relationships to disclose

Kevin Kamis, MPH: No financial relationships to disclose

Ruth Kanatser: No financial relationships to disclose

Hannan M. Braun, MD: No financial relationships to disclose